Postoperative Pain After Full Pulpotomy With TheraCal PT, Biodentin, and MTA
Launched by CUMHURIYET UNIVERSITY · Mar 11, 2025
Trial Information
Current as of April 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how different materials used during a dental procedure called pulpotomy affect pain after surgery. Pulpotomy is often performed on teeth with a condition known as symptomatic irreversible pulpitis, where the pulp (the innermost part of the tooth) becomes inflamed and painful. In this study, researchers will compare three materials—TheraCal PT, Biodentin, and MTA—to see which one leads to less pain after the procedure. The trial will involve 51 healthy adults aged 18 to 45 who have specific dental issues, including deep decay and sensitivity in their teeth.
Participants can expect to have their lower first molar treated while under local anesthesia. The study will assess their pain levels before and after the procedure at several intervals over the week. To be eligible, participants should not have any systemic diseases or serious dental problems and must respond positively to certain sensitivity tests on their teeth. This research aims to help dentists make better decisions about pain management in similar dental treatments, ultimately improving patient care and comfort.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age range should be between 18 and 45,
- • 2. Systemic disease should be absent,
- • 3. Apical periodontitis findings may or may not be present,
- • 4. Irreversible pulpitis symptoms should be present,
- • 5. The apex of the tooth should be closed,
- • 6. Pulp sensitivity tests (cold test and electric pulp test) should respond positively,
- • 7. Periodontal pocket depth and mobility should be within normal limits,
- • 8. Rubber dam isolation should be provided for the tooth to be treated,
- • 9. Restorative treatment of the tooth should be performed,
- • 10. The patient's mouth opening should be sufficient.
- Exclusion Criteria:
- • 1. The patient has any systemic disease (including conditions requiring prophylaxis),
- • 2. The patient has mental or psychiatric disorders,
- • 3. The patient has any allergic condition,
- • 4. The patient has used painkillers in the last 12 hours before the procedure and antibiotics in the last week,
- • 5. There is a loss of material in an amount that cannot be restoratively treated,
- • 6. The presence of a fistula tract or abscess,
- • 7. A negative response to pulp sensitivity tests (cold test and electric pulp test),
- • 8. No bleeding in the pulp or failure to achieve hemostasis within 6 minutes after total pulpotomy,
- • 9. The apex is open,
- • 10. Advanced canal calcification is observed on periapical radiography,
- • 11. The presence of internal or external root resorption.
About Cumhuriyet University
Cumhuriyet University is a distinguished academic institution located in Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative studies that aim to enhance healthcare outcomes. With a focus on interdisciplinary collaboration, Cumhuriyet University fosters an environment conducive to rigorous scientific inquiry and ethical research practices, ensuring that trials conducted under its auspices adhere to the highest standards of quality and integrity. Through its dedicated efforts, the university contributes significantly to the global body of medical knowledge and the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sivas, , Turkey
Sivas, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported